TIAA CREF Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $220M | Buy |
1,539,767
+184,878
| +14% | +$26.4M | 0.16% | 131 |
|
|
2018
Q4 | $168M | Buy |
1,354,889
+22,717
| +2% | +$2.82M | 0.13% | 153 |
|
|
2018
Q3 | $224M | Buy |
1,332,172
+15,607
| +1% | +$2.62M | 0.15% | 147 |
|
|
2018
Q2 | $227M | Buy |
1,316,565
+75,113
| +6% | +$12.9M | 0.15% | 146 |
|
|
2018
Q1 | $187M | Buy |
1,241,452
+259,422
| +26% | +$39.2M | 0.13% | 169 |
|
|
2017
Q4 | $132M | Sell |
982,030
-72,301
| -7% | -$9.74M | 0.09% | 240 |
|
|
2017
Q3 | $154M | Buy |
1,054,331
+353,101
| +50% | +$51.6M | 0.11% | 207 |
|
|
2017
Q2 | $109M | Buy |
701,230
+37,682
| +6% | +$5.86M | 0.08% | 267 |
|
|
2017
Q1 | $96.3M | Buy |
663,548
+425,042
| +178% | +$61.7M | 0.07% | 298 |
|
|
2016
Q4 | $26M | Buy |
238,506
+57,609
| +32% | +$6.28M | 0.02% | 658 |
|
|
2016
Q3 | $22K | Sell |
180,897
-24,805
| -12% | -$3.01K | 0.01% | 736 |
|
|
2016
Q2 | $29.1M | Sell |
205,702
-138,441
| -40% | -$19.6M | 0.02% | 593 |
|
|
2016
Q1 | $44.9M | Sell |
344,143
-132,608
| -28% | -$17.3M | 0.03% | 464 |
|
|
2015
Q4 | $67M | Sell |
476,751
-14,922
| -3% | -$2.1M | 0.05% | 363 |
|
|
2015
Q3 | $65.3M | Sell |
491,673
-443
| -0.1% | -$58.8K | 0.05% | 364 |
|
|
2015
Q2 | $86.6M | Sell |
492,116
-20,120
| -4% | -$3.54M | 0.06% | 322 |
|
|
2015
Q1 | $88.5M | Sell |
512,236
-11,681
| -2% | -$2.02M | 0.06% | 335 |
|
|
2014
Q4 | $85.8M | Buy |
523,917
+89,690
| +21% | +$14.7M | 0.06% | 342 |
|
|
2014
Q3 | $69.7M | Buy |
434,227
+245
| +0.1% | +$39.3K | 0.05% | 381 |
|
|
2014
Q2 | $63.8M | Sell |
433,982
-269,595
| -38% | -$39.6M | 0.04% | 413 |
|
|
2014
Q1 | $97.6M | Sell |
703,577
-262,799
| -27% | -$36.4M | 0.07% | 314 |
|
|
2013
Q4 | $122M | Buy |
966,376
+7,223
| +0.8% | +$914K | 0.09% | 253 |
|
|
2013
Q3 | $88.2M | Buy |
959,153
+222,873
| +30% | +$20.5M | 0.07% | 305 |
|
|
2013
Q2 | $50.6M | Buy |
+736,280
| New | +$50.6M | 0.04% | 446 |
|